These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29495204)

  • 1. [Association between DRD2 gene polymorphisms and the dosage used on methadone maintenance treatment program].
    Duan LX; Li XL; Hu PW; Luo R; Luo X; Chen YY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):194-198. PubMed ID: 29495204
    [No Abstract]   [Full Text] [Related]  

  • 2. Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study.
    Bawor M; Dennis BB; Tan C; Pare G; Varenbut M; Daiter J; Plater C; Worster A; Marsh DC; Steiner M; Anglin R; Desai D; Thabane L; Samaan Z
    Addict Sci Clin Pract; 2015 Oct; 10():19. PubMed ID: 26437921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.
    Doehring A; Hentig Nv; Graff J; Salamat S; Schmidt M; Geisslinger G; Harder S; Lötsch J
    Pharmacogenet Genomics; 2009 Jun; 19(6):407-14. PubMed ID: 19373123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.
    Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Fernández-Espejo E; Estivill X; Torrens M
    Mol Diagn Ther; 2010 Jun; 14(3):171-8. PubMed ID: 20560679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of
    Duan L; Li X; Yan J; Chen Y; Luo R; Zhang Q; Feng X; Li X
    Genet Test Mol Biomarkers; 2020 Jun; 24(6):364-369. PubMed ID: 32407152
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient perception of methadone dose adequacy in methadone maintenance treatment: The role of perceived participation in dosage decisions.
    Trujols J; González-Saiz F; Manresa MJ; Alcaraz S; Batlle F; Duran-Sindreu S; Pérez de Los Cobos J
    Patient Educ Couns; 2017 May; 100(5):981-986. PubMed ID: 27988071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
    Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of SNP-SNP interaction among ABCB1, ARRB2, DRD1 and OPRD1 on methadone dosage requirement in Han Chinese patients.
    Luo R; Li X; Qin S; Luo Z; Luo X; Hu P; Liu Z; Feng X; Li X
    Pharmacogenomics; 2017 Dec; 18(18):1659-1670. PubMed ID: 29173032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.
    Crettol S; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Déglon JJ; Preisig M; Eap CB
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1722-7. PubMed ID: 18687376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse.
    Spellicy CJ; Kosten TR; Hamon SC; Harding MJ; Nielsen DA
    Pharmacogenet Genomics; 2013 Jul; 23(7):333-40. PubMed ID: 23635803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients.
    Hung CC; Chiou MH; Huang BH; Hsieh YW; Hsieh TJ; Huang CL; Lane HY
    Pharmacogenomics; 2011 Nov; 12(11):1525-33. PubMed ID: 21902500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCB1 Polymorphisms and Cold Pressor Pain Responses: Opioid-Dependent Patients on Methadone Maintenance Therapy.
    Zahari Z; Lee CS; Ibrahim MA; Musa N; Mohd Yasin MA; Lee YY; Tan SC; Mohamad N; Ismail R
    Nurs Res; 2017; 66(2):134-144. PubMed ID: 28252574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity.
    Mouly S; Bloch V; Peoc'h K; Houze P; Labat L; Ksouda K; Simoneau G; Declèves X; Bergmann JF; Scherrmann JM; Laplanche JL; Lepine JP; Vorspan F
    Br J Clin Pharmacol; 2015 Jun; 79(6):967-77. PubMed ID: 25556837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population.
    Albonaim A; Fazel H; Sharafshah A; Omarmeli V; Rezaei S; Ajamian F; Keshavarz P
    J Addict Dis; 2017; 36(4):227-235. PubMed ID: 28786760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments.
    Barratt DT; Coller JK; Somogyi AA
    Am J Med Genet B Neuropsychiatr Genet; 2006 Jun; 141B(4):323-31. PubMed ID: 16583408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APBB2 is associated with amphetamine use and plasma beta-amyloids in patients receiving methadone maintenance treatment.
    Liu CC; Fang CP; Liu TH; Kuo HW; Liu SC; Wang SC; Chen ACH; Liu YL
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():92-98. PubMed ID: 29330135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction.
    Levran O; Peles E; Randesi M; Shu X; Ott J; Shen PH; Adelson M; Kreek MJ
    Pharmacogenomics; 2013 May; 14(7):755-68. PubMed ID: 23651024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment.
    Lawford BR; Young RM; Noble EP; Sargent J; Rowell J; Shadforth S; Zhang X; Ritchie T
    Am J Med Genet; 2000 Oct; 96(5):592-8. PubMed ID: 11054765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
    Oueslati B; Moula O; Ghachem R
    Pharmacogenomics; 2018 Jun; 19(8):741-747. PubMed ID: 29785888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between polymorphisms of DRD2 and DRD4 and opioid dependence: evidence from the current studies.
    Chen D; Liu F; Shang Q; Song X; Miao X; Wang Z
    Am J Med Genet B Neuropsychiatr Genet; 2011 Sep; 156B(6):661-70. PubMed ID: 21714067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.